Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Yale Journal of Biology and Medicine|July 1, 2010
Expressive aphasia as a presentation of encephalitis with Bartonella henselae infection in an immunocompetent adultCarla B Marienfeld, Daniel B Dicapua, Gordon K Sze, et al.
Journal of the American College of Radiology : JACR|April 5, 2014
Radiology practice environment: options, variations, and differences-a report of the ACR commission on human resourcesSharon C Dutton, Gordon K Sze, Philip L Lund, et al.
Neurocritical Care|August 14, 2015
Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and DesignKevin N Sheth, Jordan J Elm, Lauren A Beslow, et al.
Spine|August 24, 2013
Lumbar disc nomenclature: version 2.0: recommendations of the combined task forces of the North American Spine Society, the American Society of Spine Radiology, and the American Society of NeuroradiologyDavid F Fardon, Alan L Williams, Edward J Dohring, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 29, 2014
Lumbar disc nomenclature: version 2.0: Recommendations of the combined task forces of the North American Spine Society, the American Society of Spine Radiology and the American Society of NeuroradiologyDavid F Fardon, Alan L Williams, Edward J Dohring, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 3, 2019
Poor Outcomes Related to Anterior Extension of Large Hemispheric Infarction: Topographic Analysis of GAMES-RP Trial MRI ScansSeyedmehdi Payabvash, Guido J Falcone, Gordon K Sze, et al.
Stroke|May 24, 2018
Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory AnalysisKevin N Sheth, Nils H Petersen, Ken Cheung, et al.
The Lancet. Neurology|August 28, 2016
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trialKevin N Sheth, Jordan J Elm, Bradley J Molyneaux, et al.
Pageof 1